Clinical trial

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

NCT00293670

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1997-05-01

PhasePHASE4

Study timeline

Study start (unknown)1997-05-01Date precision: month

Registry last updated2006-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Patients With T1-4 Advanced Prostate Cancerunresolved

Interventions

Goserelin (Zoladex)DRUG

Sponsors & collaborators

Tampere Universitylead sponsor

Finnish Prostate Cancer Groupcollaborator

Mapped research locations

TampereFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00293670 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.